Concepedia

Ritu Lal

RL

14

Publications

1.1K

Citations

14

H-Index

1998

Active since

Affiliations

Pharmacyclics (United States)(Current)

Xenobe Research Institute

Abbott Fund

Quest Research Institute

Ritu Lal is an author at Pharmacyclics (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1998–2018

14

Publications

14

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 468 citations · Full text

Influence of Cardiac Output on Dexmedetomidine Pharmacokinetics

Sandeep Dutta, Ritu Lal, Michael D. Karol et al. · Journal of Pharmaceutical Sciences · 2000 · 120 citations

, , +7

Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen

Ritu Lal, Juthamas Sukbuntherng, Ezra Tai et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 84 citations

Arbaclofen Placarbil Decreases Postprandial Reflux in Patients With Gastroesophageal Reflux Disease

Lauren B. Gerson, Jacob F Huff, Amine Hila et al. · The American Journal of Gastroenterology · 2009 · 79 citations

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine

Ritu Lal, Juthamas Sukbuntherng, Wendy Luo et al. · British Journal of Clinical Pharmacology · 2010 · 55 citations · Full text

Rows per page

1–5 of 14